Variant NB.1.8.1 accounted for 0% of U.S. cases in April. By mid-June, it was estimated to be the cause of around 37% of cases.

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

At the same time a new COVID variant has been reported in the U.S., residents of Illinois and across the nation will likely ...

The newly reconstituted CDC Advisory Committee on Immunization Practices will meet this week. Packed with antivaxxers, the ...

Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England ...

Robert F. Kennedy Jr. (RFK Jr.) has only been Secretary of the Department of Health and Human Services (HHS) since ...

A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...

That's because the variant — NB.1.8.1. or “Nimbus” — may cause painful sore throats. The symptom has been identified by ...

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...